Search results
Google promotes iOS 18 RCS integration in new ad
Financial Express· 13 hours agoLupin Limited has received tentative approval from the U.S. FDA for its generic equivalent of Descovy Tablets, a HIV medication. The product will be...
USFDA gives tentative nod to Lupin’s generic formulation to treat HIV infection
Financial Express· 19 hours agoGlobal pharma major Lupin Limited on Wednesday announced that it has received tentative approval...
Lupin receives US FDA tentative approval for Emtricitabine, Tenofovir Alafenamide Tablets, 200 mg/25...
The Economic Times· 19 hours agoThis product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low...
The evolving landscape of head and neck cancer care in India
Financial Express· 5 days agoEach year, more than 5.5 lakh patients are diagnosed with Head and Neck Cancers (HNC), representing...
Option Strategy of the day| Long build up in MCX, Bull call spread recommended
CNBC Awaaz· 6 days agoMCX stock has witnessed significant long built up from the last week of July.
F&O stocks to buy today: M&M, DLF among top 7 trading ideas for July 30, 2024
The Economic Times· 2 days agoAugust futures ended flat on Monday, with cumulative Open Interest up 0.63%. FIIs sold Rs 2,474.54...
'If domestic flows into equities slow down': Nomura India shares Nifty target, says this on LTCG,...
Business Today· 7 days agoStock market outlook: Nomura India said it remains constructive in the long term, given macro...
Vedanta shares gain 3.8% on S&P Global Ratings upgrade of UK parent
Business Standard India· 6 days agoShares of the Mumbai-listed Vedanta closed at Rs 447, up Rs 16.4, or 3.8 per cent over the previous...
USFDA scrutiny impacts drug approvals for domestic pharma companies | Delhi News - Times of India
The Times of India· 2 days agoNew Delhi: Regulatory scrutiny in the US has cast a dark cloud on approvals for new drugs from domestic generic biggies in the world’s most lucrative pharma market. Major companies, including ...